Michael J Fisher
Affiliation: The Children's Hospital of Philadelphia
- Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysisMichael J Fisher
Division of Oncology, The Children s Hospital of Philadelphia, Colket Translational Research Building, 10th Floor, 3501 Civic Center Blvd, Philadelphia, Pennsylvania 19104, USA
Neuro Oncol 14:790-7. 2012..The lack of consensus regarding the indications for treatment underlines the need for better standardization of care. Future clinical trials for OPG require standardized visual assessment methods and clear definitions of visual outcomes...
- The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progressionMichael J Fisher
Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
J Neurooncol 87:165-71. 2008..We hypothesized that PN tumors with high metabolic activity as demonstrated by FDG-PET are more likely to progress in the following year...
- Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapyMichael J Fisher
Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
Pediatr Blood Cancer 43:780-4. 2004..Larger studies will help clarify these findings...
- Factitious fungus in two children with cancer receiving liposomal amphotericinMichael J Fisher
Department of Pediatrics, Children s Hospital of Philadelphia, Pennsylvania 19104, USA
J Pediatr Hematol Oncol 24:360-3. 2002..These cases underscore the importance of establishing a microbiologic diagnosis in cases of presumed fungal infection...
- Headache as a risk factor for neurovascular events in pediatric brain tumor patientsSarah M Kranick
Department of Neurology, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
Neurology 80:1452-6. 2013..To determine whether severe recurrent headache is a risk factor for neurovascular events in children who received radiation for brain tumors...
- Childhood intracranial ependymoma: twenty-year experience from a single institutionHui Kuo G Shu
Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 30322, USA
Cancer 110:432-41. 2007..In this article, they report their 20-year institutional experience with this disease...
- Retinal nerve fiber layer thickness in children with optic pathway gliomasRobert A Avery
Division of Ophthalmology, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Am J Ophthalmol 151:542-9.e2. 2011..To determine the relationship of high-contrast visual acuity (VA) and low-contrast letter acuity with retinal nerve fiber layer (RNFL) thickness in children with optic pathway gliomas...
- Optic pathway gliomas: neoplasms, not hamartomasGrant T Liu
Neuro Ophthalmology Service, Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
JAMA Ophthalmol 131:646-50. 2013..Optic pathway gliomas are an important neuro-ophthalmic cause of vision loss in children. Their management depends on whether they are considered neoplasms or hamartomas...
- Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomasEugene I Hwang
Division of Oncology, Center for Cancer and Blood Disorders, Children s National Medical Center, Washington, District of Columbia, USA
Pediatr Blood Cancer 60:776-82. 2013..Bevacizumab-based therapy has demonstrated encouraging responses; however, longer-term toxicity, response durability and alternative dosing regimens have not been evaluated...
- Cranial irradiation increases risk of stroke in pediatric brain tumor survivorsCynthia J Campen
Department of Radiology, Children s Hospital of Philadelphia, and Department of Neurology, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Stroke 43:3035-40. 2012..The purposes of this study were to determine the incidence of neurovascular events as late complications in pediatric patients with brain tumor and to evaluate radiation as a risk factor...
- Surgical treatment of brain tumors in infants younger than six months of age and review of the literatureShih Shan Lang
Department of Neurosurgery, University of Pennsylvania Medical Center, Division of Neurosurgery, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
World Neurosurg 78:137-44. 2012..These tumors can be challenging to treat surgically. We analyzed a modern series of patients treated by a multidisciplinary team at a tertiary care center and performed a literature review of this unique population...
- Gliomatosis cerebri: 20 years of experience at the Children's Hospital of PhiladelphiaGregory T Armstrong
Division of Oncology, The Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Cancer 107:1597-606. 2006..In this report, the authors describe the largest cohort of children to date with GC and explore relations between potential prognostic factors, treatment, and survival...
- Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II studyBrian Weiss
Division of Oncology, Cincinnati Children s Hospital Medical Center, Cancer and Blood Diseases Institute, Cincinnati, Ohio B W, J P Division of Genetics, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio E S Division of Clinical Pharmacology, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio A V National Cancer Institute, Pediatric Oncology Branch, Bethesda, Maryland B C W, E D, P W Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama B K Department of Preventitive Medicine, University of Alabama at Birmingham, Birmingham, Alabama A C Department of Neurology, Boston Children s Hospital, Boston, Massachusetts N U Department of Neurology, Washington University, St Louis, Missouri D H G Children s National Health System, Center for Neuroscience and Behavioral Medicine, Washington, DC R J P Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania M J F Division of Genetics, Primary Children s Hospital, Salt Lake City, Utah D V Division of Neurology, The University of Chicago Medicine Comer Children s Hospital, Chicago, British Columbia
Neuro Oncol 17:596-603. 2015..Converging evidence has demonstrated that the NF1 tumor suppressor protein, neurofibromin, negatively regulates activity in the mammalian Target of Rapamycin pathway...
- Pediatric low-grade gliomasAngela J Sievert
Division of Oncology, Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
J Child Neurol 24:1397-408. 2009..Second-line radiotherapy can also improve overall survival but is associated with more frequent and significant neurocognitive, endocrine, and other long-term toxicities...
- Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging eraMary Kara Bucci
Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Cancer 101:817-24. 2004..Because few reports on outcome in patients with pediatric malignant gliomas during the magnetic resonance imaging era were available, the authors studied the outcomes of children with these tumors at their institution...
- MRI features of plexiform neurofibromas involving the liver and pancreas in children with neurofibromatosis type 1Jorge Delgado
Department of Radiology, The Children s Hospital of Philadelphia, 34th and Civic Center Boulevard, Philadelphia, PA, USA Electronic address
Clin Radiol 69:e280-4. 2014..To describe magnetic resonance imaging (MRI) findings of plexiform neurofibromas (PNF) involving the liver and pancreas in paediatric patients with neurofibromatosis type 1 (NF1)...